Shares in Getinge Group climbed in early trading on Thursday as the medical technology company reported a sharp increase in profitability, driven largely by a favorable shift in U.S. trade policy.
The firm’s profit rose by approximately 50%, a jump that investors are attributing to the reversal of tariff pressures that had previously weighed on its margins.
The company’s CFO, Agneta Palmér, acknowledged the improved tariff situation but cautioned that the broader trade environment remains complex and subject to change.
The positive market reaction comes as the Trump administration begins disbursing refunds for tariffs imposed on imported goods, a move that marks a tangible pivot in U.S. trade strategy.
For Getinge, which has significant exposure to the American market, this development transforms a former cost burden into a financial benefit.
The company’s CFO, Agneta Palmér, acknowledged the improved tariff situation but cautioned that the broader trade environment remains complex and subject to change.
This development aligns with a broader easing of trade tensions that has begun to lift sentiment across European industrials.